MIRA PHARMACEUTICALS, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Operating expenses | $10.5M | $8.0M | $8.5M | $7.0M |
| Cash from operations | -$4.7M | -$5.6M | -$4.5M | -$5.6M |
| Total assets | $11.1M | $2.9M | $4.9M | $858,074 |
| Total liabilities | $702,068 | $723,349 | $558,097 | $1.5M |
Shares outstanding 42.0M · Free float 70.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.